Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 86 citing articles:

Stem cell-based therapy for human diseases
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 617
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications
Xinyu Qiao, Junhao Yin, Zhihuan Zheng, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
Cármen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Cláudio Luciano Franck, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
NSP4 and ORF9b of SARS-CoV-2 Induce Pro-Inflammatory Mitochondrial DNA Release in Inner Membrane-Derived Vesicles
Md Imam Faizan, Rituparna Kundu Chaudhuri, Shakti Sagar, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2969-2969
Open Access | Times Cited: 44
The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
Shou Zhen Wang, Yiming Li, Bingqing Wang, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 35
Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation
Siyu Wang, Tao Yang, Tiantian Li, et al.
Chinese Medical Journal (2025)
Open Access | Times Cited: 1
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Advanced research on extracellular vesicles based oral drug delivery systems
Mengdi Song, Mingxiao Cui, Zhou Fang, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 560-572
Closed Access | Times Cited: 31
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
Tiantian Li, Bo Zhang, Hui Fang, et al.
EBioMedicine (2023) Vol. 92, pp. 104600-104600
Open Access | Times Cited: 22
Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis
Ming Wang, Ning Zhao, Chengshuo Wang, et al.
Allergy (2023) Vol. 78, Iss. 6, pp. 1425-1440
Open Access | Times Cited: 20
Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic
Dailin Yuan, Yufei Bao, Ahmed El-Hashash
American Journal of Stem Cells (2024) Vol. 13, Iss. 2, pp. 37-58
Open Access | Times Cited: 6
Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges
Tiantian Li, Ze-Rui Wang, Weiqi Yao, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 9, pp. 900-911
Open Access | Times Cited: 25
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis
Weiqi Yao, Haibo Dong, Ji Qi, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101545-101545
Open Access | Times Cited: 21
Clinical progress in MSC-based therapies for the management of severe COVID-19
Maria Rossello-Gelabert, Ainhoa Gonzalez‐Pujana, Manoli Igartúa, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 68, pp. 25-36
Open Access | Times Cited: 20
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial
Ellen Gorman, Jennifer Rynne, Hannah J. Gardiner, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 3, pp. 256-269
Open Access | Times Cited: 12
Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs and their derivates
Yesuf Adem Siraj, Umberto Galderisi, Nicola Alessio
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 12
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials
Qinxue Liu, Fengjie Ma, Yizhi Zhong, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Mesenchymal stem cells and their derived exosomes for ALI/ARDS: A promising therapy
Dan Liang, Chang Liu, Mei Yang
Heliyon (2023) Vol. 9, Iss. 10, pp. e20387-e20387
Open Access | Times Cited: 11
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín‐Quirós, et al.
Cytotherapy (2023) Vol. 26, Iss. 1, pp. 25-35
Closed Access | Times Cited: 11
Viruses and neurodegeneration: a growing concern
Samia A. Shouman, Nadine Hesham, Tamer Z. Salem
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Airway Basal Stem Cells Inflammatory Alterations in COVID‐19 and Mitigation by Mesenchymal Stem Cells
Shuyan Du, Jing Jin, Chunli Tang, et al.
Cell Proliferation (2025)
Open Access
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial
Mengqi Yuan, Le Song, Ze-Rui Wang, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Long COVID: current research and future directions
Rongling Zhang, Xiaoying Gu, Hui Zhang, et al.
Infectious Diseases & Immunity (2025)
Open Access
Page 1 - Next Page

Scroll to top